A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
More about Open Access at the CrickAuthors list
J Mateo D Chakravarty R Dienstmann S Jezdic A Gonzalez-Perez N Lopez-Bigas CKY Ng PL Bedard G Tortora JY Douillard EM Van Allen N Schultz Charles Swanton F André L PusztaiAbstract
In order to facilitate implementation of precision medicine in clinical management of cancer, there is a need to harmonise and standardise the reporting and interpretation of clinically relevant genomics data.
Journal details
Journal Annals of Oncology
Volume 29
Issue number 9
Pages 1895-1902
Available online
Publication date
Full text links
Publisher website (DOI) 10.1093/annonc/mdy263
Europe PubMed Central 30137196
Pubmed 30137196